Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-1,676
Closed -$235K 294
2024
Q3
$235K Buy
+1,676
New +$218K 0.01% 258
2024
Q2
Sell
-1,865
Closed -$277K 298
2024
Q1
$277K Sell
1,865
-154
-8% -$22.5K 0.01% 258
2023
Q4
$294K Sell
2,019
-301
-13% -$44.4K 0.01% 242
2023
Q3
$346K Buy
2,320
+348
+18% +$58.3K 0.02% 208
2023
Q2
$342K Buy
+1,972
New +$352K 0.02% 207
2020
Q4
Sell
-2,891
Closed -$397K 207
2020
Q3
$397K Buy
+2,891
New +$399K 0.03% 165
2019
Q3
Sell
-1,165
Closed -$201K 216
2019
Q2
$201K Buy
+1,165
New +$196K 0.02% 222

Other funds holding DEO

Aspiriant LLC's DEO Position: Q4 2024 in Review

Aspiriant LLC sold out of Diageo (DEO) in Q4 2024, closing a stake of 1,676 shares — an estimated $235K sold.

Aspiriant LLC first reported a position in DEO in Q2 2019 and held it in 7 quarters. The position peaked at $397K in Q3 2020. 970 funds tracked by Wall St. Rank hold DEO as of Q4 2024.

  • Aspiriant LLC reported no remaining Diageo position as of Q4 2024 after selling out during the quarter.
  • Aspiriant LLC sold 1,676 Diageo shares in Q4 2024, an estimated $235K.
  • Aspiriant LLC first reported a position in Diageo in Q2 2019 and held it in 7 quarters.
  • Aspiriant LLC's Diageo position peaked at $397K in Q3 2020.
  • 970 funds tracked by Wall St. Rank held Diageo as of Q4 2024.

Based on Aspiriant LLC's 13F filing for Q4 2024, filed 16 Jan 2025.